logo

For the Inventor, By the Inventor

Hyogo, Japan

Yoshio Toyomaki

This inventor holds 4 USPTO granted patents. Top assignee: Nippon Zoki Pharmaceutical Co., Ltd.. Active years: 1982-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshio Toyomaki. Retrieved from https://idiyas.com/inventor/yoshio-toyomaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 1.8

ph-index = 3

Forward Citations = 45(Granted Patents)


Location History:

  • Nara, JP (1982)
  • Katoh, JP (1991)
  • Hyogo, JP (1991)

Company Filing History:

goldMedal4 out of 148 
 
Nippon Zoki Pharmaceutical Co., Ltd.
 patents

Years Active: 1982-1991

Loading Chart...
4 patents (USPTO):Explore Patents
1. 5057324 - Kallikrein inhibitor substance, a process for preparation and (1991-10-15),
2. 4985453 - Parabanic acid derivatives and pharmaceutical compositions thereof (1991-01-15),
3. 4985354 - Method of assaying kallikrein formation substances (1991-01-15),
4. 4364947 - Vincamine derivatives useful as cerebral metabolic and circulatory (1982-12-21),

Title: Innovations of Yoshio Toyomaki

Introduction

Yoshio Toyomaki is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of substances that have therapeutic applications. With a total of four patents to his name, Toyomaki's work focuses on innovative solutions for health-related challenges.

Latest Patents

Toyomaki's latest patents include a kallikrein inhibitor substance and a process for its preparation. This novel substance exhibits inhibitory action against the formation of kallikrein, making it useful as a drug for anti-inflammatory, analgesic, and antiallergic purposes. Another significant patent involves a method of assaying kallikrein formation substances. This method activates blood coagulation factor XII in plasma in the presence of the physiologically active substance being tested, converting prekallikrein into kallikrein and allowing for the measurement of the activity of the kallikrein formed.

Career Highlights

Yoshio Toyomaki is currently associated with Nippon Zoki Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work has been instrumental in advancing the understanding and treatment of various medical conditions.

Collaborations

Toyomaki has collaborated with notable colleagues, including Katsumi Nishikawa and Hitoshi Kawakubo. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical products.

Conclusion

Yoshio Toyomaki's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to impact the development of therapeutic agents that address critical health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…